2021
DOI: 10.1101/2021.09.09.459619
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

ATM-deficiency induced microglial activation promotes neurodegeneration in Ataxia-Telangiectasia

Abstract: While ATM loss-of-function has long been identified as the genetic cause of Ataxia Telangiectasia (AT), how this genetic mutation leads to selective and progressive cerebellar degeneration of Purkinje and granule cells remains unknown. We performed single-nucleus RNA-sequencing of the human cerebellum and prefrontal cortex from individuals with AT and matched unaffected controls to identify AT-associated transcriptomic changes in a cell-type- and brain-region-specific manner. We provide the largest single-nucl… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
18
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3
3

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(22 citation statements)
references
References 103 publications
(94 reference statements)
0
18
0
Order By: Relevance
“…Next, we compared the list of transcripts found to be differentially expressed in CMVMJD135 mice with 40 different datasets of previously reported DEGs, which include, among others, data on the microglial signature program [ 49 , 50 ] on other neurodegenerative disorders [ 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 ], aging [ 38 , 51 , 63 ], disease-associated microglia (DAM) [ 64 ], and injury-related microglia [ 38 , 51 ]. We found a significant overlap with only 3 of the 40 published gene sets, namely with the DEGs seen in microglia of a mouse model of amyotrophic lateral sclerosis (ALS), the SOD1 G93A mouse model [ 52 ]; of a mouse model of Alzheimer disease (AD), the App NL-G-F/NL-G-F mouse model [ 52 ]; and with a list of microglial genes highly expressed and/or affected in different neuroinflammatory conditions [ 65 ] ( Figure S13 in Supplementary Results and Supplementary Data 2 ).…”
Section: Resultsmentioning
confidence: 99%
“…Next, we compared the list of transcripts found to be differentially expressed in CMVMJD135 mice with 40 different datasets of previously reported DEGs, which include, among others, data on the microglial signature program [ 49 , 50 ] on other neurodegenerative disorders [ 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 ], aging [ 38 , 51 , 63 ], disease-associated microglia (DAM) [ 64 ], and injury-related microglia [ 38 , 51 ]. We found a significant overlap with only 3 of the 40 published gene sets, namely with the DEGs seen in microglia of a mouse model of amyotrophic lateral sclerosis (ALS), the SOD1 G93A mouse model [ 52 ]; of a mouse model of Alzheimer disease (AD), the App NL-G-F/NL-G-F mouse model [ 52 ]; and with a list of microglial genes highly expressed and/or affected in different neuroinflammatory conditions [ 65 ] ( Figure S13 in Supplementary Results and Supplementary Data 2 ).…”
Section: Resultsmentioning
confidence: 99%
“…To determine whether the NF-κB pathway is regulated in human disease, we analysed the microglia transcriptomes from a single-nucleus RNA-sequencing dataset of human cerebellum (CB) from individuals with A–T and healthy controls ( 33 ). Enrichment analyses of canonical and non-canonical NF-κB pathway gene sets of A–T versus control cerebellar microglia were performed.…”
Section: Resultsmentioning
confidence: 99%
“…Indeed, in murine model of A–T, microglia-induced neurotoxicity was dependent on secretion of IL-1β ( 12 ). In addition, microglia from individuals with A–T show enrichment of genes associated with cytokine production ( 33 ). We propose that initial activation of the non-canonical NF-κB pathway in the presence of unrepaired DNA damage could promote the release of cytokines in the extracellular compartment, thus establishing the local pro-inflammatory environment.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations